03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Maxipime 1g* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | GSK |
Manufacturer | Pharmaline SAL* |
Manufacturing Type | Pharmaline Licensed by Glaxo SmithKline Export Ltd , UK |
Origin | Lebanon |
ATC | J01DE01 |
Revision Date | 14/10/2013 |
Maxipime 1g* :
Maxipime 1g* :
Maxipime 1g* :
Maxipime 1g* :
Maxipime 1g* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Maxipime 1g* :
Maxipime 1g* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Rare |
Agranulocytosis | Not known |
Allergic reaction | Rare |
ALT increased | Common |
Anaemia | Common |
Anaphylactic shock | Not known |
Aplastic anemia | Not known |
Arthralgia (Pain joint) (Joint ache) | Rare |
AST increased | Common |
Blood alkaline phosphatase increased | Common |
Blood bilirubin increased | Common |
Blood creatinine increased | Uncommon |
Blood urea increased | Uncommon |
Candidiasis (Candida infection) | Rare |
Cephalea | Uncommon |
Chills | Rare |
Colitis | Uncommon |
Coma | Not known |
Confusion | Not known |
Constipation | Rare |
Convulsion | Rare |
Coombs test positive | Very Common |
Diarrhoea (Diarrhea) | Common |
Disturbances in consciousness | Not known |
Dizziness | Rare |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Rare |
Dyspnoea (dyspnea) | Rare |
Encephalopathy | Not known |
Eosinophilia | Common |
Erythema | Uncommon |
Erythema multiforme | Not known |
Fever | Uncommon |
Gastrointestinal disorders | Not known |
Haemolytic anemia | Not known |
Haemorrhage | Not known |
Hallucination | Not known |
Infusion site inflammation | Uncommon |
Infusion site irritation | Common |
Injection site inflammation | Common |
Injection site pain | Common |
Leucopenia (Leukopenia) | Uncommon |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Myoclonus | Not known |
Nausea | Uncommon |
Nephropathy toxic | Not known |
Neutropenia | Uncommon |
Oedema | Rare |
Oral candidiasis | Uncommon |
Paraesthesia (paresthesia) | Rare |
Prothrombin time prolonged | Common |
Pruritus | Uncommon |
Pruritus genital | Rare |
Pseudomembranous colitis | Uncommon |
Renal insufficiency | Not known |
Skin rash | Common |
Stevens-Johnson syndrome | Not known |
Stupor | Not known |
Thrombocytopenia (Thrombopenia) | Uncommon |
Thromboplastin time prolonged | Common |
Tinnitus | Rare |
Urticaria | Uncommon |
Vaginitis | Uncommon |
Vasodilation | Rare |
Vomiting | Uncommon |
Maxipime 1g* :
NB : Products With Same Indication |
Different Units By MoH Code
Maxipime 1g* MoH 7392 :
Form | Powder for solution for injection |
Packaging | Bottle |
Package Size | 1+2 |
Strength | 1g |
Storage Condition | 15-30°C protect from light |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 96725/12 |
Submission date | 01/01/2012 |
Registration Year | 2014 |
Archived Date | 02/07/2020 |
Price Comparison
● Country: | Oman | |
● Package Size: | 1 | |
● Public Price: | 6.38 OMR | ( 1,472,082.92 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 6,38 OMR | ( 1,384,404.00 LBP ) |
● Pricing Date: | 10/04/2016 | |
● Type: | Medicine Non Marketed |
● Country: | Qatar | |
● Package Size: | 1 | |
● Public Price: | 56.75 QAR | ( 1,393,666.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 56,75 QAR | ( 1,375,248.00 LBP ) |
● Pharmacy Price: | 46.56 QAR | ( 1143420.48 LBP ) |
● Pricing Date: | 20/07/2017 | |
● Type: | Medicine Non Marketed |
● Country: | UAE | |
● Package Size: | 1 Vial (Dry) | |
● Public Price: | 56 AED | ( 1,353,016.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 56 AED | ( 1,353,016.00 LBP ) |
● Pharmacy Price: | 45.11 AED | ( 1089902.71 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 1 Vial (Dry) | |
● Public Price: | 56 AED | ( 1,353,016.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 56 AED | ( 1,353,016.00 LBP ) |
● Pharmacy Price: | 45.11 AED | ( 1089902.71 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 1 | |
● Public Price: | 298.22 CZK | ( 1,138,902.18 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 298,22 CZK | ( 1,138,062.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 1 | |
● Public Price: | 46 SAR | ( 1,087,440.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 46 SAR | ( 1,087,440.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Belgium | |
● Package Size: | 3 | |
● Public Price: | 26.74 EUR | ( 2,590,464.24 LBP ) |
● Pack size unit used: | 3 | |
● Cost/Unit: | 8,9133 EUR | ( 775,008.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 18/05/2019 | |
● Type: | Medicine Withdrawn |
● Country: | Italy | |
● Package Size: | 1 | |
● Public Price: | 8.54 EUR | ( 827,321.04 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 8,54 EUR | ( 775,008.00 LBP ) |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 1 vial + 1 ampolla de disolvente | |
● Public Price: | 7.29 EUR | ( 706,226.04 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 7,29 EUR | ( 678,132.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File